Delivery Order SPE2DB25D3008-SPE2DB25FRDJF
- Not listed
- The Defense Logistics Agency awarded a $15,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on July 28, 2025, with an ultimate completion date of August 18, 2025. This non-competitive, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of TUKYSA 150 mg tablets (120 count) with a contract value of $12,697.69. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, carries no set-aside designation and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $12,674.74 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a completion date of October 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,756.32 firm fixed price delivery order for TUKYSA 150 MG tablets (120 count units) on August 18, 2025, with completion scheduled for September 9, 2025. This is a non-set-aside, competitively awarded contract with performance to be completed at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $12.7K delivery order to AmerisourceBergen Drug Corp for 120 tablets of TUKYSA 150 MG on June 20, 2025, with completion targeted for July 14, 2025. This is a firm fixed-price contract with no set-aside designation, awarded competitively through the vendor's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for TUKYSA 50 mg tablets (60-count unit dose packaging) under a firm fixed-price contract valued at $6,306.64. This non-set-aside award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a $6,337.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on September 5, 2025, with an ultimate completion date of September 26, 2025. This non-competitive, non-set-aside award represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $15,756.32. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TUKYSA is a prescription oncology medication, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TUKYSA 150 mg tablets (120 count units) with a ceiling value of $15,756.32. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $15,756.32 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 26, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDJFDelivery Order
The Defense Logistics Agency awarded a $12,697.69 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for TUKYSA 150 mg tablets (120 count) with a completion date of October 15, 2025. This competitively awarded, firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, demonstrating the vendor's capability to compete openly for federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company's comprehensive SPE2DX contract vehicle enables supply of specialty medications, brand-name and generic pharmaceuticals, vaccines, and related medical commodities to support Defense Health Agency operations and other government healthcare entities worldwide. This delivery order for TUKYSA reflects the ongoing pharmaceutical supply needs of the federal healthcare infrastructure managed through DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 9/23/25 |